# Screening of Cancer Patients to Assess Impact of COVID-19

> **NCT04373005** · — · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 83 (actual)

## Conditions studied

- Covid-19
- Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Nasopharyngeal (NP) swab

## Key facts

- **NCT ID:** NCT04373005
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-05-11
- **Primary completion:** 2022-10-06
- **Final completion:** 2022-10-06
- **Target enrollment:** 83 (ACTUAL)
- **Why stopped:** Participants were not testing positive for COVID-19 and were not returning onsite for visits.
- **Last updated:** 2025-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04373005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04373005, "Screening of Cancer Patients to Assess Impact of COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04373005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*